Antibiotics for Children With Severe Diarrhoea

PHASE3CompletedINTERVENTIONAL
Enrollment

8,268

Participants

Timeline

Start Date

May 13, 2017

Primary Completion Date

January 15, 2020

Study Completion Date

January 15, 2020

Conditions
Diarrhea
Interventions
DRUG

Azithromycin

Participants will receive rehydration, dietary counseling, one 20 mg tablet of zinc per day and 10 mg (0.35 ml) / kg of azithromycin syrup per day, for three days

OTHER

Placebo

Participants will receive rehydration, dietary counseling, one 20 mg tablet of zinc per day and 0.25 ml / kg of placebo drug syrup per day, for three days

Trial Locations (7)

Unknown

Icddr,B, Dhaka

Centre for Public Health Kinetics, New Delhi

Kenya Medical Research Institute, Nairobi

Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre

Centre pour le Développement des Vaccins (CVD-Mali), Bamako

Aga Khan University, Karachi

Muhimbili University of Health and Allied Sciences, Dar es Salaam

Sponsors
All Listed Sponsors
collaborator

International Centre for Diarrhoeal Disease Research, Bangladesh

OTHER

collaborator

Center for Public Health Kinetics

OTHER

collaborator

Kenya Medical Research Institute

OTHER

collaborator

University of Washington

OTHER

collaborator

Malawi-Liverpool-Wellcome Trust Clinical Research Programme

OTHER

collaborator

University of Liverpool

OTHER

collaborator

Centre pour le developpement des vaccines, Mali

UNKNOWN

collaborator

University of Maryland, College Park

OTHER

collaborator

Aga Khan University

OTHER

collaborator

Muhimbili University of Health and Allied Sciences

OTHER

collaborator

Boston Children's Hospital

OTHER

lead

World Health Organization

OTHER